Simon JK, Kennedy SB, Mahon BE, Dubey SA, et al. Immunogenicity of rVSVDeltaG-ZEBOV-GP Ebola vaccine (ERVEBO(R)) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials. Vaccine 2022 Oct 5. pii: S0264-410X(22)01145.
PMID: 36208978